Alzamend Neuro
Financial ratios & Valuation

Forward Multiples (2026 – 2028)

202620272028
Price/Earnings ratio
-4.23-11.851.70
Price/Sales ratio
N/A6.671.58
Earnings per Share (EPS)
$-0.56$-0.2$1.39

Historical Multiples (2016 – 2024)

2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.81K-247.65-1.23K-163.24-218.79-188.34-7.31-3.48-0.48-3.28-191.02
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-3.15M-664.69496.532.50K1.17K486.896.7917.00-1.858.64828.73
Price/Cash Flow ratio
-18.06K-274.44-561.29-759.47-410.04-361.39-13.71-5.80-0.58-6.14-584.75
Price/Free Cash Flow ratio
-18.06K-274.44-561.29-759.47-410.04-361.39-13.50-5.80-0.57-6.06-584.75
Price/Earnings Growth ratio
N/A-0.1315.46-0.248.64-11.70-0.07-0.360.010.024.33
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A1.36%96.43%3.01%0.31%-3.11%-0.34%0.97%N/AN/A0.15%
Return on Assets
-226.87%-1186.68%-38.56%-323.96%-242.35%-178.66%-85.45%-251.50%-1575.03%-181.62%-283.16%
Return On Equity
65524.52%268.39%-40.17%-1534.32%-535.02%-258.50%-92.90%-488.52%383.46%-157.65%-1034.67%
Return on Capital Employed
65524.52%264.71%-38.73%-1580.51%-538.40%-246.00%-92.27%-488.27%383.07%-263.47%-1059.46%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A3.18N/A
Quick Ratio
0.180.0724.971.261.823.2512.372.030.142.791.54
Cash ratio
0.030.005.630.030.092.1412.071.790.112.790.06
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/A45.41K21.04KN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.104.46N/A0.000.000.11N/AN/A0.470.310.00
Debt Equity Ratio
-29.41-1.01N/A0.000.000.16N/AN/A-0.110.450.00
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
1.0393.43N/A0.000.000.14N/AN/A-0.13N/A0.07
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-1.98KN/A
Cash Flow to Debt Ratio
-5.93-2.39N/A-13.17K-37.43K-8.08N/AN/A-27.50N/A-25.30K
Company Equity Multiplier
-288.81-0.221.044.732.201.441.081.94-0.241.451.82
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1111111.0111.011.011
Cash Flow Coverage Ratio
-5.93-2.39N/A-13.17K-37.43K-8.08N/AN/A-27.50N/A-25.30K
Short Term Coverage Ratio
-5.93-2.39N/A-13.17K-37.43K-8.08N/AN/A-27.50N/A-25.30K
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A